UK markets closed

Zynerba Pharmaceuticals, Inc. (0M40.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.8398-0.0902 (-9.70%)
At close: 04:23PM BST

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • j
    Can't figure out this stock! I should be in a steady climb back towards the $5 mark but it is on a yoyo! Either way, I am long on this one and waiting patiently for 2023 results.
  • B
    CFRA: QUANTITATIVE STOCK REPORT | September 16, 2022 | NasdaqGM : ZYNE
    Zynerba Pharmaceuticals, Inc.
    Recommendation [as of September 15, 2022]: BUY
    Risk Evaluation: HIGH Price: 1.090 (Sep 16, 2022 close) Trading Currency: USD Country: United States
  • S
    Bottoms here time to load up
  • S
    2023 will be a huge year better buy soon $$$$
  • C
    You can't fight the fed. Or the algo's that constantly manipulate this stock.
  • j
    climbing up the ladder again...but oh so slowly! Looking for this to breakout soon!
  • s
    Well, we are at a buck...the top three guys make over 2 million.....have they bot any stock or do they think Zygel is a failure
  • H
    nice finish
  • s
    guess the pink sheets are coming...make sure u all tell Ceo Anido he is doing a good job
  • f
    I’ve been in this for a while! I believe as soon as this trial is done and zygel is proven effective, ^^^going up! In 2 yrs could be bigggggggg!
  • r
    robert strom
    AMT sales
  • S
    If you can't take the heat
  • H
    Does anybody work there ? Andino getting paid well for zero….
  • j
    sure is quiet! What's up? Anybody?
  • j
    I like the up but the big sell everyday at close is irritating. I just want to see this company succeed and make me whole again! I’m looking forward to successful results from the trials!
  • S
    Right direction 🍀
  • j
    well, it moves up then steps back with lots of small action trades but it is going up and to the right! Patience is required here until the trial finishes, I am holding.
  • R

    More or less...

    2018 GWPH FDA approval Epidiodex first Cannabis compond

    2020 FDA expanded broader labeling approved expanded market

    2021 Sales rise to about $550MM rather quickly

    Acquired by Jazz for about $7BB or 14x sales

    Where will OUR PAL go...comparatively speaking...???

    There are only three reasons why ANYBODY FAILS AT ANYTHING...
    1. Lack of MOTIVATION
    2. Lack of INFORMATION
    3. Lack of SKILL OR ABILITY

    Can THEY pull this off...???

    Do THEY WANT TO pull this off, or are they just happy to be there...???

    Do they have the knowledge, saavyness, STREETnavigation, negotiating skills, interpersonal skills...???

    The formulation APPEARS to work and add/have have many other great ideas that have not made it.

    They were bailed out by Covid...reprieve. Two years. 20MM additional shares worth.

    I personally believe 1000 monkeys, at 1000 typewriters, given an infinity of time, will eventually type the Constitution word by word. I personally have the time. Wall Street doesn't. One more shot. We shall see.
  • A
    Time to buy ZYNE
  • R
    This line of credit is basically agreeing that Zyne will have a much higher EPS in the near future. The line of credit let’s Zyne decide when to sell and at what price. No lender would go along with those terms unless they were sure the EPS would increase(and probably dramatically)